G-Protein Coupled Receptors (GPCRs) Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032
Overview
The G-Protein Coupled Receptors (GPCRs) Market size was valued at USD 3.92 Billion in 2025 and the total G-Protein Coupled Receptors (GPCRs) revenue is expected to grow at a CAGR of 6.7% from 2026 to 2032, reaching nearly USD 6.17 Billion.
G-Protein Coupled Receptors (GPCRs) Market Overview:
G-protein coupled receptors (GPCRs), also known as seven-(pass)-Trans membrane receptors, are a varied collection of membrane receptors. These are found in the cell membrane and are responsible for binding external chemicals and transmitting signals from them to an intracellular molecule.
To know about the Research Methodology :- Request Free Sample Report
G-Protein Coupled Receptors (GPCRs) Market Dynamics:
Rising prevalence of cancer is the major factor driving the market growth.
The rising number of cancer cases, as well as the rising frequency of lifestyle-related diseases such as cardiovascular infections and respiratory difficulties, is expected to boost the G-protein coupled receptors market. G-protein coupled receptors (GPCRs) are extremely useful in the development of novel pharmaceuticals. Furthermore, the market is expected to rise as government funding for R&D efforts in medication discovery and development increases.
The availability of a large number of licenced pharmaceutical medications that target these receptors is also helping to propel the market forward. In , around 700 medicines targeting G protein-coupled receptors were approved (GPCRs). Furthermore, the demand for associated assays is increasing as a result of an expanding number of allosteric modulators, biological medicines, and biassed agonists that target these receptors.
The development of successful drug discovery strategies are aided by advances in computational approaches to simplify receptor structure. Researchers from the University of Southern California, the Skolkovo Institute of Science and Technology, and the Moscow Institute of Physics and Technology used a computational technique to build a thermally stable GPCR for drug formulation.
However, the high price of G-protein coupled receptors (GPCRs) cell lines are expected to be a substantial market growth barrier. Unfavorable reimbursement rules, particularly in developing markets, may exacerbate market growth issues. The market's growth pace will be restrained further by a scarcity of experienced individuals or qualified expertise.
The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
G-Protein Coupled Receptors (GPCRs) Market Segment Analysis:
The Global G-Protein Coupled Receptors (GPCRs) Market is segmented on the basis of Assay Type and Application.
Based on Assay Type, the cAMP Assays segment accounted for the leading market share xx% in 2025. Because cyclic Adenosine Monophosphate (cAMP) is a key intracellular second messenger in GPCR signal transduction, the cAMP assays segment dominated the global market. The presence of a diverse product range in terms of reagent kits for measuring cAMP messenger levels is also propelling the industry forward. Because of the benefits associated with the use of calcium flux assays, such as high sensitivity, convenience in estimating calcium flux, and user configurability, the calcium level detection assays segment is predicted to grow at the lucrative CAGR during the forecast period.
Based on Application, oncology segment is expected to dominate the global market during the forecast period. G-protein coupled receptors are the biggest protein superfamily in the human genome, with over 700 genes discovered. GPCRs are involved in a number of physiological processes, ranging from sensory modulation to hormone responses. Signalling through GPCRs has recently been shown to alter several elements of cancer biology, such as invasion, migration, and vascular remoulding, thanks to a focus on fundamental and clinical research. It has also been discovered that some types of cells express over 150 different GPCRs, one of which is expressed at a rather high level. This validates biomarker-based research in the industry, paving the way for the development of lead candidates that target GPCRs.
G-Protein Coupled Receptors (GPCRs) Market Recent Developments:
| Date | Company | Development | Impact |
|---|---|---|---|
| 19 January 2025 | Exicure, Inc. | Exicure executed a definitive share purchase agreement to acquire 100% of the equity securities of GPCR Therapeutics USA Inc., a developer of therapeutics targeting G-protein coupled receptor heterocomplexes. | The acquisition, combined with a concurrent license agreement, allows Exicure to expand its clinical portfolio and commercialize advanced technologies targeting the CXCR4 and ADRB2 receptor pathways. |
| 13 March 2025 | Sosei Heptares | The company advanced its proprietary AI-driven structure-based drug design (SBDD) platform to resolve high-resolution cryo-EM structures for historically challenging Class B GPCR targets. | This technological milestone accelerates the discovery of small-molecule allosteric modulators, significantly reducing preclinical discovery timelines for metabolic and endocrine diseases. |
| 28 July 2025 | Tectonic Therapeutic | The company successfully initiated a Phase II clinical evaluation for its leading biologic candidate targeting a cardiovascular GPCR pathway. | This progression marks a shift toward highly specific GPCR-targeted monoclonal antibodies, reducing the off-target side effects commonly associated with traditional small molecules. |
| 04 November 2025 | Structure Therapeutics Inc. | The company expanded its global R&D infrastructure by opening a specialized facility dedicated to screening oral small-molecule GLP-1 receptor agonists. | The facility scales up high-throughput screening capacity, driving growth in the high-demand GPCR-focused obesity and cardiometabolic therapeutics sector. |
| 17 February 2026 | Confo Therapeutics | Confo Therapeutics achieved a major milestone in its research collaboration by discovering conformation-selective VHH antibodies (Confibodies) for an undisclosed orphan GPCR. | The development unlocks previously undruggable targets, triggering a milestone payment and expanding the pipeline for severe rare neurological disorders. |
G-Protein Coupled Receptors (GPCRs) Market Regional Insights:
North America is dominated the global market in 2025.
Because of strategic investments in cancer research, approval of GPCR-targeted medications, and a greater focus on drug discovery and development operations, North America led the global G-protein coupled receptors market in 2025. In November, the FDA approved 134 GPCR targets for pharmaceuticals in the United States or the European Union, with 128 targets included in the FDA orange book.
APAC is expected to witness lucrative market growth during forecast period.
Due to the economic development of countries such as China and India, as well as increased government investment in the biotechnology and biopharmaceutical sector, rising life expectancy, rising per capita income, and unmet market needs in the region, the Asia-Pacific region is expected to grow at a significant rate during the forecast period. Furthermore, due to the existence of various developing firms such as Sosei Heptares and NB Health Laboratory, Asia Pacific is expected to be the fastest-growing regional market. Regional growth is fueled by the amount of growth activities performed by enterprises to expand their market position.
The report also helps in understanding Global G-Protein Coupled Receptors (GPCRs) Market dynamics, structure by analyzing the market segments and project the Global G-Protein Coupled Receptors (GPCRs) Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global G-Protein Coupled Receptors (GPCRs) Market make the report investor’s guide.
G-Protein Coupled Receptors (GPCRs) Market Scope: Inquire before buying
| Global G-Protein Coupled Receptors Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 3.92 Bn. |
| Forecast Period 2026 to 2032 CAGR: | 6.7% | Market Size in 2032: | USD 6.17 Bn. |
| Segments Covered: | by Product | Cell Lines Detection Kits Cell Culture Reagents Ligands |
|
| by Assay Type | cAMP Functional Assays Calcium Functional Assays β-Arrestin Functional Assays Radioligand Binding and GTPγS Functional Assays Internalization Assays Trafficking Assays Other Assays |
||
| by Application | Cancer Research CNS Research Metabolic Research Cardiovascular Research Respiratory Research Inflammation Research Other Application |
||
G-Protein Coupled Receptors (GPCRs) Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
G-Protein Coupled Receptors (GPCRs) Market, Key players:
1. Thermo Fisher Scientific, Inc.
2. Becton, and Dickinson and Company
3. Abcam plc.
4. Enzo Life Sciences, Inc.
5. Promega Corporation.
6. PerkinElmer Inc.
7. QIAGEN
8. Merck KGaA
9. HD Biosciences Co., Ltd
10. Cisbio Bioassays
11. Eurofins DiscoverX Products.
12. Actelion Pharmaceuticals Ltd
13. Accure Pharma
14. Anchor Therapeutics.
15. Arena Pharmaceuticals, Inc.
16. ADDEX THERAPEUTICS
17. WuXi AppTec
18. BioInvenu, Inc.
19. Molecular Devices, LLC.
20. Corning Incorporated
Frequently Asked Questions:
1. Which region has the largest share in Global Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global market?
Ans: The Global Market is growing at a CAGR of 6.7% during forecasting period 2026-2032.
3. What is scope of the Global Market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Market?
Ans: The important key players in the Global Market are Promega Corporation., PerkinElmer Inc., QIAGEN, Merck KGaA, HD Biosciences Co., Ltd, Cisbio Bioassays, Eurofins DiscoverX Products., Actelion Pharmaceuticals Ltd, Accure Pharma, Anchor Therapeutics., Arena Pharmaceuticals, Inc., ADDEX THERAPEUTICS, WuXi AppTec, BioInvenu, Inc., Molecular Devices, LLC., and Corning Incorporated
5. What was the Global G-Protein Coupled Receptors (GPCRs) Market size in 2025?
Ans: The Global G-Protein Coupled Receptors (GPCRs) Market size was USD 3.92 Billion in 2025.